Smaller CROs May Do It Better, Quicker – Especially in Times of Crisis
Pursuit of a path from discovery to drug approval as quickly as possible is a clear objective for most biotech…
Looking for Key Clinical Trial Vendor Management Strategies?
Clinical trials, and in particular oncology studies, can be very complex and often involve multiple parties: Sponsor, CRO (sometimes several…
Consider This Region for Your Phase 3 Global Trial
As of May 2020 ClinicalTrials.gov lists 16,150 oncology trials registered as Recruiting, Not yet Recruiting Studies, and the chart below…
Recommendations for Quicker CTA Negotiation
Whether in Canada or any other country it is no secret that executing Clinical Trial Agreements (CTAs) is often the…
Overcome Today’s New Enrollment Challenges
Choose Your Specialized CRO Partner Well The global clinical trials market is expected to reach $69.8 billion US by 2027,…
CRAs Play a Supporting Role in Patient-Centric Trials
There is an ever-present desire in the clinical trial industry to practice ‘patient-centricity’. This practice is featured predominantly during the…
Collaborative Vendor Teaming for Better Oncology Trial Results – Real World Evidence
Workplace collaboration requires a willingness to find solutions to problems, together with others. Which means that any successful collaborative vendor…
The Role of Ethics from a Clinical Research Associate’s Perspective: Patient-Centered Research
A contract research organization (CRO) functions as the intermediary between a biopharma company sponsoring clinical trials and the research sites…
Hassle-Free Site Selection and Study Start-up for Clinical Trials in Canada
It is no secret that Canada’s presence as a key player in the field of pharmaceutical drug development is rapidly…
Do You Believe the Myths About Conducting Clinical Trials in Canada?
Myths exist to explain things we don’t understand, as well as to continue traditions and keep relationships and societies ‘safe’.…